Expanding swiftly in the U.S., the health-tech enterprise, Medicai, founded by a Romanian, aims for significant expansion.
Medicai, a Romanian medical imaging and health data platform, has been making significant strides in the United States market. Last year, the company had five clients in the US, a number that has since grown to 25. By 2025, Medicai's management expects to have 50 clients in the US, surpassing the number in Romania.
Founded in 2019 by Mircea Popa (CEO), Alexandru Artimon (CTO), and Andrei Blaj (COO), Medicai offers a cloud-native health data platform that enables doctors, clinics, and hospitals to securely store, manage, and share medical images and health data. The platform acts as a versatile cloud-based PACS platform, connecting to imaging equipment such as CT, MRI, or X-ray machines.
Medicai's rapid expansion into the US market began in 2023, following its relocation of operations to the US. The company's clients primarily include healthcare providers, US attorneys specializing in personal injury or workers' compensation, veterinary clinics, companies offering industrial imaging services, and pharmaceutical/medical research companies conducting multicentric clinical trials.
According to Andrei Blaj, Medicai's Co-founder and Chief Operating Officer, customers in the US make decisions quickly, and contracts are often signed in less than a month from the first contact. By the end of 2025, Medicai estimates that US revenues will represent more than 50% of its business, up from 30% currently and 10% at the beginning of this year.
The expansion into the US market required an investment of approximately EUR 200,000. Currently, Medicai has 11 employees in Romania and one person in Florida, US. In the last year, Medicai has increased its recurring revenue from the US fourfold and expects a 10-fold increase in 2025 versus 2024.
Doctors can access and analyze images and medical data directly from the web or a mobile application through the Medicai platform. Medicai currently has 70 customers in Romania, the US, the UK, India, and other countries such as Spain, Brazil, Germany, France, Austria, Saudi Arabia, and Costa Rica.
While there is no publicly available data or announcements about how many clients Medicai expects to have in the US by 2025, the company's rapid growth and success in the US market suggest a promising future.
Science continues to play a crucial role in Medicai's growth, as advancements in technology enable the company to develop more efficient and secure health data management solutions. By 2025, it's expected that health-and-wellness technology will account for a significant portion of Medicai's operations, due to the increasing demand for digital health solutions within the US market.
